The Cholecystokinin Antagonist Proglumide Enhances the Analgesic Effect of Dihydrocodeine

@article{McCleane2003TheCA,
  title={The Cholecystokinin Antagonist Proglumide Enhances the Analgesic Effect of Dihydrocodeine},
  author={G. McCleane},
  journal={The Clinical Journal of Pain},
  year={2003},
  volume={19},
  pages={200-201}
}
  • G. McCleane
  • Published 2003
  • Medicine
  • The Clinical Journal of Pain
AimTo investigate the potential pro-analgesic effect of the non-specific CCK antagonist proglumide on the analgesia produced by dihydrocodeine. MethodA double-blind, placebo-controlled crossover study of 30 adult subjects. ResultsMean pain scores fell from a baseline of 8.12–7.89 during the placebo phase (N.S.) and to 6.82 during the proglumide phase (P < 0.05). Side effects were minor. ConclusionThe CCK antagonist proglumide enhances the analgesic effect of dihydrocodeine. 
Pharmacological strategies in relieving neuropathic pain
  • G. McCleane
  • Medicine
  • Expert opinion on pharmacotherapy
  • 2004
Mechanisms of opioid-induced tolerance and hyperalgesia.
  • A. DuPen, Danny Shen, M. Ersek
  • Medicine
  • Pain management nursing : official journal of the American Society of Pain Management Nurses
  • 2007
Novel Pharmacological Nonopioid Therapies in Chronic Pain
Endogenous opiates and behavior: 2003
...
1
2
3
...

References

SHOWING 1-10 OF 13 REFERENCES
The Cholecystokinin Antagonist Proglumide Enhances the Analgesic Efficacy of Morphine in Humans with Chronic Benign Pain
Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia.
Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide
Regulation of morphine antiallodynic efficacy by cholecystokinin in a model of neuropathic pain in rats.
The CCK-B receptor antagonist Cl 988 reverses tolerance to morphine in rats.
...
1
2
...